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Detoxification is a fundamental function for all living organisms that need to excrete catabolites and toxins tomaintain homeostasis.
Kidneys are major organs of detoxification that maintain water and electrolyte balance to preserve physiological functions of
vertebrates. In insects, the renal function is carried out by Malpighian tubules and nephrocytes. Due to differences in their
circulation, the renal systems of mammalians and insects differ in their functional modalities, yet carry out similar biochemical
and physiological functions and share extensive genetic and molecular similarities. Evolutionary conservation can be leveraged to
model specific aspects of the complex mammalian kidney function in the genetic powerhouse Drosophila melanogaster to study
how genes interact in diseased states. Here, we compare the human and Drosophila renal systems and present selected fly disease
models.
1. Introduction
Defective kidney function can lead to potentially lethal
end-stage renal disease (ESRD) and chronic kidney disease
(CKD), for which therapeutic options are limited. ESRD
and CKD may be remedied by dialysis and renal replace-
ment therapy (renal transplant), which are both costly [1]
and greatly affect the quality of life of both patients and
their families. The complexity of the human kidney has
posed a formidable challenge to experimental probing for
many pathologies. In many cases disease progression is
well described; however, the underlying mechanisms at the
molecular and cellular levels are incompletely understood,
which affects our capacity to design remedial therapeutics.
Animal model research on kidney disease has traditionally
used rodents for their mammalian-type kidney similar to
the human one. However, rodent and human kidneys also
share the same complexity, which challenges experimenta-
tion. Zebrafish, featuring a streamlined pronephros, has also
been used to model renal disease, albeit less frequently, in
part because of its adaptation to an aquatic environment.
With an open circulatory system, the fly’s renal system
is aglomerular and urine formation is based on active
transport rather than selective readsorption [2]. However,
Drosophila is a clear evolutionary intermediate towards the
glomerular kidney, with recognizable cell types responsible
for fulfilling the kidney’s main functions: detoxification,
filtration, and endocytosis [3, 4]. The small body size and the
fastest filtration rate known [5] allow flies to have separate
compartments for renal function: the Malpighian Tubules
(MTs), which are analogous to the renal tubules [6], and
two clusters of nephrocytes within the body cavity, which are
analogous to podocytes in the glomerular kidney. Because of
extensive functional similarities, the fly has been successfully
used to model aspects of mammalian renal function. We
will compare the human and Drosophila renal systems and
discuss the strategic use of fly modeling of human renal
disease.
2. The Human Renal Filtration System
The human kidneys, found in the mid to lower back of the
trunk on each side of the spine, are bean-shaped organs
roughly the size of a person’s own fist. Composed of two
main layers, the cortex and the medulla, they play a leading
role in blood filtration, solute reabsorption, and metabolic
waste excretion, which result in urine production.The kidney
medulla contains so-called renal pyramids, conical regions
collectively holding about onemillion functional units, which
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Figure 1: Comparison of the human podocyte and the Drosophila nephrocyte slit diaphragms. Selected evolutionary conserved proteins are
indicated.The same symbols indicate orthologous proteins between human andDrosophila. In the fly, Duf was found to directly interact with
Pyd and Sns with podocin ortholog Mec-2 [6].
are called nephrons. The nephrons span both cortex and
medulla, starting and ending in the former, with the latter
containing variable lengths of the central portion of the
tubule. Nephronsmodify the filtered fluid and produce urine,
which drains into collecting tubules (also called collecting
ducts) that in turn fuse into larger ducts that empty into the
minor calyx, the ureter and, eventually, the bladder.
Each nephron consists of a tubule closed at one end
and enlarged into the cup-like Bowman’s capsule, which
surrounds a tuft of capillaries called glomerulus. Together, the
Bowman’s capsule and glomerulus are referred to as renal (or
Malpighian) corpuscle. The renal corpuscle filters blood via
specialized cells that respond to physiological cues. Glomeru-
lar capillaries are fenestrated, that is have pores which allow
fluids and small molecules such as ions and sugars to leave
the blood and, instead, retain cells and proteins exceeding
pore size, complexes of carrier proteins and lipids, as well
as calcium ions (Ca2+). Wrapped around the capillaries and
with characteristic protrusions called foot processes which
contact the capillary’s basement membrane are podocytes,
specialized epithelial cells integral to the filtration barrier [6–
8]. Adjacent foot processes are separated by slit diaphragms
about 14 nm wide with 30–50 nm wide pores carrying out fil-
tration [6] (Figure 1).Major components of the slit diaphragm
include members of the nephrin protein superfamily and
NEPH1, which are coexpressed and form the diaphragm via
homotypical and heterotypical interactions [6]. Together, the
basementmembrane, slit diaphragm, and podocyte processes
form a barrier between plasma and filtrate which is essential
to glomerular function. Its disruption can lead to kidney
disease [9]. Differences in pressure between the glomerulus
and Bowman’s capsule determine the glomerular filtration
rate (GFR, the amount of filtrate produced per minute),
which is used to measure kidney function. Because ion
and fluid balance depend on flow efficiency, glomerular
filtration rate is subject to multiple regulatory mechanisms.
The glomerular filtrate is first collected in the Bowman’s
capsule and directed through the nephron, flowing through
the proximal convoluted tubule and the descending and
ascending branches of the Loop of Henle, rising through the
distal convoluted tubule while being modified, and, finally,
arriving to the collecting duct as urine (Figure 2).
2.1. Human Nephron Development. Mammalian nephrons
formduring the late embryonic and early postnatal stages and
display limited cell turnover, resulting in low regeneration
rate in the adult [10]. Interactions between two mesoderm-
derived tissues, the ureteric bud (UB), and the adjacent
metanephric mesenchyme (MM) initiate nephrogenesis [10].
In part driven by developmental regulators Ret, Gfra1, Wnt11,
Wnt6, and Pax2 in the UB and Bmp4, Gdnf, Pax2, and Wt1
in the MM, the UB invades the adjacent MM, generating the
collecting duct [10–16]. The UB then branches to form a T
shape within the MM. The two ends of the T structure then
induce formation of the cap mesenchyme, which contains
nephron stem cells and progenitors, as well as stromal cells
that support kidney ontogenesis by producing signaling
molecules, for example retinoic acid, promoting expression
of Ret, ERK, MAPK, PI3K, PLC, andWNT [14, 17–20] in the
UB.The iteration of this process produces both the branched
structure of the ducts and nephron multiplicity. The MM
cells then aggregate and, responding to Wnt signaling [21],
undergo mesenchymal-to-epithelial transition to produce
the renal vesicle or nephron progenitor [10–13]. Vesicle
cells polarize, first establishing a proximal-to-distal axis [22]
followed by an apical-basal one [23, 24]. After polarization,

















































Figure 2: Schematic features of a generalized human nephron. The glomerulus, the different regions of the nephron, and corresponding ion
and solute transport are indicated. The dashed arrows depict direction of the fluid flow.
the renal vesicle reshapes in the form of a comma, then
that of an S, and fuses with the UB, while cells differentiate
morphologically [10, 25]. The S-shaped body gives rise to
the glomerulus, Bowman’s capsule, and both proximal and
distal tubules. The intermediate region of the S-shaped body,
instead, yields the loop ofHenle [26].Mesangial cells, integral
to the glomerulus, derive from the stromal cells [15, 27].
Finally, the vasculature is formed by mesodermal cells that
migrate into the developing kidney [28].
3. The Drosophila Renal System
In the fly, filtration is carried out by specialized cells called
nephrocytes, which display remarkable similarities to the
human podocytes [6]. Nephrocytes were originally discov-
ered in the 1800s and found to uptake and store multiple
compounds, including silver nitrate, albumin, and dyes [29–
34]. Nephrocytes are found in two clusters: one, called
pericardial, near the tubular heart and the other, called
garland, harboring two nuclei, close to the esophagus [6, 32–
36]. Drosophila nephrocytes display characteristic in-folding
of the plasma membrane which form channels flanked by
foot processes [6]. Ultrastructural studies have revealed
that nephrocytes form a three-layered filter morphologically
similar to that formed by the vertebrate podocytes [6, 32–34,
36, 37]. Like human podocytes, pericardial nephrocytes filter
and reabsorb solutes from the Drosophila circulating fluid,
called haemolymph, via channels regulated by 30 nmwide slit
diaphragms [38–40]. Slit diaphragms feature two filaments
composed of proteins encoded by genes sticks and stones
(sns) and dumbfounded (duf, also called kirre), a NEPH1
ortholog [6]. Other protein components of the nephrocyte
slit diaphragm include the products of genes mec-2, a
podocin ortholog, and pyd, a ZO-1 ortholog [6]. Alike human
podocytes, a basement membrane enwraps each nephrocyte.
Together, the nephrocyte diaphragm and the basementmem-
brane form the filtration barrier inDrosophila, the integrity of
which is maintained by protein-protein interactions between
orthologs of the human slit diaphragm proteins (Figure 1).
The filtrate is actively endocytosed from the sides of the
channels, retained in cell vacuoles and either broken down
(proteins) or stored (toxins, silver nitrate) [41]. The recent
findings that nephrocytes may be apicobasally and baso-
laterally polarized reinforced their similarity with human
podocytes [42, 43]. Moreover, nephrocytes and podocytes
appear to respond similarly to pharmacological treatment.
Administration of puromycin [44] and protamine sulfate [42]
was found to disrupt the filtration barrier. Because of their
extensive functional overlap with the necessary podocytes,
the discovery that nephrocytes are, instead, dispensable in the
adult fly, yet necessary for larval survival [45], was surprising
and future studies are being targeted to understand this
apparent paradox.
Nephrocytes have been used to model human nephrotic
syndromes, in which podocyte processes are effaced as a
consequence of mutations in the genes encoding for slit
diaphragmproteins. Because thesemodels have been recently
reviewed, we refer interested readers to [46].
3.1. Malpighian Tubule Morphology. In Drosophila two pairs
of MTs are made of a single-layered epithelium and depart
from the interface between mid- and hind-gut (Figure 3).
With one tubule residing more anteriorly and the other more
posteriorly within the abdominal cavity, the MTs are folded
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Figure 3: Schematic features of the Drosophila Malpighian tubules. The anterior and posterior tubules with relative functional segments and
ion and water transport are indicated. Dashed arrows depict the direction of the fluid flow. Features and functions of principal and stellate
cells are shown (below).
in a stereotypical way, which is thought to ensure efficient
metabolic waste removal and osmoregulation in the open
circulatory system typical of insects. Unlike the mammalian
closed circulatory system in which the circulating fluid is
subject to glomerular ultrafiltration,Drosophila haemolymph
is, instead, filtered. Also different from the mammalian
nephrons that are embedded in organ tissues, the twoMTs are
free inside the fly’s body cavity and can be cleanly microdis-
sected. Anterior and posteriorMTs can be distinguished both
functionally and morphologically, because of their distinct
transcriptomes and the anterior tubule being longer [47].
The anterior tubule pair can be divided into four sections:
initial, transitional, main, and terminal (Figure 3). These
regions contain type I cells, known as principal cells, and
type II cells, known as stellate cells (Figure 3). Principal cells
arise from a key interaction between the midgut and the
hindgut, constitute about ∼80% of all tubule cells, and are
responsible for the transport of cations and organic solutes
[48]. Stellate cells are scattered around the principal cells and
are responsible for water and chloride ion (Cl−) flow [48, 49].
Reducing tubular expression of the vacuolar- (V-) ATPase
by using fruit flies heterozygous for a lethal insertion in the
gene encoding for the V-ATPase beta subunit revealed that
cation transport may solely be performed by principal cells
[50]. Stellate cells were only found in secretory regions and
were absent from reabsorptive regions, suggesting that they
may have secretory roles [50]. The cells in the MT initial
segment are thinner and may excrete specifically Ca2+ ions
at high rates [51]. Cells of the terminal segment appear to
regulate ion and water balance via selective readsorption
from and secretion into primary urine and by removing
nitrogen-containing catabolites from the haemolymph via
active transport of uric acid to the tubule lumen and passive
diffusion of other molecules through the intercellular spaces.
As the primary urine is transported along the tubule, it
is sequentially transformed, a process that requires both
apicobasal cell polarization of the tubular epithelium and
planar cell polarity. Tubular cells were found to be func-
tionally differentiated in a proximal-to-distal fashion and the
processed urine is eventually secreted by the more distal
cells. Because of their fundamental role in detoxification, the
normal development of MTs is essential in the fruit fly.
Just like human nephrons, Drosophila MTs exhibit inter-
nal marked asymmetry which corresponds to distinct spatial
domains of gene expression [50, 51]. Analyses of enhancer
trap expression in the MTs revealed that the initial, tran-
sitional, and main segment of the anterior tubules and the
sole main segment in the posterior tubules correspond to
different cell types and distinct physiological functions [50].
The main segment was found to secrete potassium chloride
(KCl) and water at high rates [52] and the lower third of
the tubule carried out reabsorption [50]. The lower regions
of the MTs appeared to modify the travelling fluid from the
main segment by reabsorbing potassium ions (K+) [53] but
not water [54], contrary to what was previously reported
[50]. Moreover, the lower tubules were found to acidify the
fluid and transport Ca2+ into the lumen (Figure 3) [53].
Remarkably, in just about 15 seconds, the cells located in
the main segment of the Drosophila MTs were found to
secrete fluid in amounts equal to their own volume, making
the MTs the fastest known filtering system [52, 54]. While
the observed functional complexity of the MTs was initially
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found surprising and in apparent contradiction with its
reputation as a simplified epithelial developmental model
[50], this same functional complexity turned out to be an
asset for modeling human renal disease in combination with
the available genetic and technological tools for probing ion
transport [52].
3.2. Ion Transport and Fluid Secretion in the Malpighian
Tubules. In the MTs, multiple ion transporters regulate ion
balance in different sections. An apical V-ATPase gener-
ates a primary proton gradient that fuels the activity of
sodium/proton (Na+/H+) and K+/H+ exchangers, also api-
cally localized, which release Na+ and K+, respectively, in the
lumen [54]. K+/Cl− cotransporters localized at the basolateral
membrane [55] decrease K+ concentration in the secreted
fluid as it passes through the lower tubule [53]. Channels
found in stellate cells transport Cl− from the haemolymph to
the lumen and are under control of the leucokinin peptide-
hormone family [49, 54]. Leucokinins are synthesized in
response to increased intracellular Ca2+ and promote both
fluid secretion and epithelial permeability to Cl− [56].
Cardioacceleratory neuropeptide CAP2b was found to
stimulate fluid secretion specifically via cyclic GMP (cGMP)
and to activate the nitric oxide (NO) signaling pathway
[52, 57] that regulates salt and water balance in the fly
MTs [58]. Early studies tested if increased concentration of
intracellular Ca2+ could stimulate CAP2b and activate the
NO/cGMP pathway in different cell types [59]. Producing the
first Ca2+ reporter system in DrosophilaMTs, Rosay and col-
laborators expressed aequorin, a Ca2+-sensitive luminescent
protein, in principal cells in the tubule main segment via the
GAL4/UAS binary expression system [59, 60]. As aequorin
was produced in the tubules in vivo, luminescence indicated
both the amount of aequorin and Ca2+ amounts. Stimulation
of CAP2b-dependent physiological responses caused rapid
Ca2+ release from internal stores [59]. Because in this system
noCAP2b stimulationwas observed in stellate cells, principal
and stellate cells of the main segment are unlikely to be
connected through gap junctions [59].
3.3. Malpighian Tubule Development. TheMTs start forming
as four primordia derived from the hindgut primordium
and visceral mesoderm in the six-hour embryo [4, 61] in a
process requiring the gap gene product Kru¨ppel (Kr) and
the transcription factor Cut [48, 62, 63]. The specification of
future tubule cells is determined via Kr [48] and, similar to
mammalian kidney development, the Wnt pathway [10, 48].
Each tubule primordium contains a unique tip cell
specified by lateral inhibition via the Notch pathway [4,
48, 64]. The tip cell segregates and activates the Epidermal
Growth Factor receptor homolog DER [65] which promotes
cell proliferation, tubular growth, and development of the
MTs excretory system [64, 65]. As the MTs grow closer to
the caudalmesoderm they inducemesenchymal-to-epithelial
transition in nearby cells that will insert themselves in the
tubules and become stellate cells [4]. The ectoderm-derived
tubular epithelium is formed of principal cells [4] and the
ureter of ectodermal cells [4]. Cells divide a definite number
of times to give rise to 146 principal and 33 stellate cells in
each anterior tubule and 105 principal and 22 stellate cells in
each posterior tubule in Drosophila [50, 66]. Most of tubule
ontogenesis is completed during embryogenesis, and theMTs
are not histolysed during metamorphosis. Using positively-
marked mosaic lineage with GFP-labeled proliferating cells
enabled the discovery of multipotent adult stem cells in the
lower tubule and ureter [4]. Such cells require JAK-STAT
signaling for self-renewal and are analogous to stem cells
activated during repair of kidney ischemic injury [4].
3.4. Immune Function of the Malpighian Tubules. The MT
epithelium is part of the fly’s defenses against pathogens.
The MTs display innate immunity with both humoral and
cellular responses and no adaptive response, as is typical
for insects [67, 68]. Remarkably, studies in Drosophila first
revealed the immune function of Toll-receptor signaling
[69]. In fact, the Toll gene, originally identified for its
function in embryonic polarity [70], was later found to
function in immunity [71] and to have a few homologs in
the fly, including “18-wheeler” [72] and multiple vertebrate
ones dubbed Toll-Like Receptors (TLRs). Unlike other fly
organs involved in immunity, the MTs display constitutive
production of antimicrobial peptides (AMPs) [73]. Upon
sensing infection, the MTs activate distinct pathways when
triggered by specific pathogens. The Toll pathway was found
to respond to fungal and Gram-positive bacterial infections
and the immune deficiency (IMD) pathway to respond to
Gram-negative bacterial infections [74, 75]. MTs may also
initiate a Toll-independent humoral response [76]. All these
eventually trigger release of seven groups of AMPs, either
directly from theMTs [73] or indirectly from the fat-body, the
latter being the fly liver-equivalent [68, 69, 77]. The groups
of AMPs, Drosomycin, Metchnikowin, Defensin, Attacin,
Cecropin, Drosocin, and Diptericin, appear to inhibit growth
of haemolymph-invading microorganisms [77]. Both the
IMD and Toll pathways were found to sense superficial
peptidoglycan on the bacterial cell wall via signaling by
peptidoglycan-recognition proteins (PGRP) in theMTs prin-
cipal cells and gut [69, 78, 79]. PGRP function has mainly
been studied in the gut [80], yet the pathway appears to func-
tion similarly in theMTs.The Toll proteins display homology
to the cytoplasmic domain of the vertebrate interleukin 1
receptor and participate into similar intracellular signaling
cascades [81]. The IMD pathway is considered to be equiv-
alent to the vertebrate TNF pathway [75]. Both Toll and IMD
pathways result in activation of NF-𝜅B-like transcription
factor Relish and induce transcriptional changes [82].
The steroid hormone ecdysone that regulates principal
and stellate cell fluid secretion [68] also affectsMT-dependent
immunity. Ecdysone may promote haemocyte proliferation
and fast pathogen encapsulation [83]. In S2 cells, ecdysone
was also found to induce transcription of the PGRP-LC gene
encoding the peptidoglycan receptor and, independently, of a
subset of AMPs [84]. Ecdysone also triggers histolysis during
metamorphosis [83]. However, the MTs are resistant to this
process, possibly due to their fundamental role in immunity.
Diap2, an antiapoptotic protein, was also found to contribute
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to the innate response in the IMD pathway, possibly via
regulation of MT ion channels [85]. Diap2 levels increased
in the MTs when there was an immune threat; conversely,
decreased Diap2 made flies more prone to infections [85].
Finally, upon septic infection, the MT-dependent
immune response may alternatively be activated via the NO
pathway, which in turn initiates the IMD pathway and leads
to increased NO Synthase (dNOS) and improved fly survival
[67, 68].
With growing appreciation for the importance of the MT
immune function, the ongoing mechanistic studies of gut-
mediated immunity will provide resources and paradigms
to better define the role of the MTs in the defense from
pathogens.
4. Malpighian Tubules to Model Disease
MTs have been utilized to study the physiology of fluid trans-
port because of their anatomical accessibility, streamlined
anatomy, and one-cell-thick epithelium. In MTs, the prolifer-
ation of the founder cells (anlage), their spatial organization,
patterning, and differentiation occur in sequence, rather than
concurrently as in other epithelia, enabling studies of separate
stages in time course experiments. MTs and mammalian
nephrons share functionally distinct regions (Figures 2 and
3), analogous functions, and display remarkable transcrip-
tome conservation [47, 86]. For example, similar to mam-
malian renal tubules, MTs carry out detoxification thanks
to high levels of cytochrome P450 and glutathione trans-
ferase [87]. Likewise, mutations in evolutionarily conserved
V-ATPase subunits were initially discovered in Drosophila
because of their renal phenotypes [88, 89]. Three years later,
equivalent mutations in the human ATP6B1 V-ATPase were
reported to cause similar defects in patients [90]. As the
interest in modeling renal function in the fly continues to
grow, we review some of the successful examples below.
4.1. Nephrolithiasis. Drosophila has been used to model the
most common kind of human kidney stones, namely, calcium
oxalate nephrolithiasis [91]. Nephrolithiasis refers to the
formation and movement of kidney stones in the urinary
tract [91]. There are multiple types of kidney stones that
are distinguished for their different composition and origin.
Largely dependent on diet and metabolism, kidney stones in
the urinary tract are most commonly composed of calcium
oxalate (CaOx) and, in lesser quantities, calcium maleate or
phosphate. Also dependent on diet and metabolism, cysts
composed of uric acid develop when urine is too acidic, for
example in severe dehydration, gout, or following chemother-
apy. Struvite cysts are caused by kidney infections and may
result in urinary obstruction [91]. Finally, cystine stones form
as crystals of leaked cystine in rare cystinuria patients. While
rats had been the model of choice for CaOx stone formation
[92], prohibitive costs of breeding and caring inspired Chen
and colleagues [92] tomodel nephrolithiasis in the fly. Similar
to rodents, flies appeared to respond to oral administration
of lithogenic agents ethylene glycol, hydroxyl-L-proline, and
sodium oxalate, by inducing formation of CaOx crystals
in the MTs between two and three weeks after ingestion.
Importantly, response severity was dose-dependent [92].
Recently, RNAi-mediated knockdown of the enzyme
xanthine dehydrogenase (Xdh) in the fly was shown to induce
ectopic calcification and accumulation of crystals and stones
in theMTs [93].Well-fed Xdh-knockdown flies only survived
three days, as opposed to 60 days of the wild type control.
Chemical analysis of the stones by micro X-ray fluorescence
revealed significant amounts of Ca2+ and zinc (Zn). Because
the latter had never been involved in kidney stone formation
before, genetic confirmationwas obtained byRNAi-mediated
inhibition of Zn transporters in the fly, which was found to
decrease stone formation [93]. Dietary and pharmacologic
modulation of Zn levels in the fly and analyses of human
kidney stones further confirmedZn as a bona fide component
[93]. In this case, theDrosophilamodel enabled the discovery
of a new contributor to nephrolithiasis and indicated Zn-
metabolic enzymes as potential therapeutic targets [93]. One
issue to be clarified is that dietary Zn intake has been
linked to increased risk of kidney stones in the adult (yet
not in adolescent) individuals, while inhibiting Zn excretion
was found to reduce cyst formation in the fly. One of the
possible ways to interpret these apparently contradicting
results posits that Zn may promote formation of different
crystals depending on concentration [94] and indicates the
need to probe additional physiological parameters in future
studies to capture the complexity of kidney stone formation.
Flies have been used to study the processes leading
to formation of uric acid stones because of their high
levels of urate crystals normally accumulating in the tubule.
Systematic analyses of the 33 genes encoding for subunits
of the V-ATPase, some of which with multiple isoforms,
revealed that mutants in the genes encoding core V-ATPase
subunits displayed transparent MTs as a result of urine
acidification, which decreased uric acid crystallization [89].
Notably, similar acidification defects were also found in
patients with mutations in two V-ATPase subunits, which
suggests a certain degree of functional conservation [90, 95].
4.2. Polycystic Kidney Disease. Polycystic kidney disease
(PKD) is a genetic disease affecting at least 12.5million people
world-wide, regardless of ethnicity [96]. Two forms of PKD
exist, one autosomal dominant (AD) and one, rarer and
more severe, which is autosomal recessive (AR) [96] and will
not be discussed here. ADPKD causes the development and
progressive enlargement of fluid-filled cysts in the nephron,
that consequently increase kidney size and cause interstitial
fibrosis and chronic kidney disease by age 55 [96]. In half
of the patients the severe damage results in kidney failure,
making dialysis or renal transplant the only treatments [96].
The lack of a cure and dialysis costs that can surpass 150,000$
per patient per year [1] make PKD a global priority.
Genetic Underpinning of PKD. More than 85% of ADPKD
patients carry mutations in the PKD1 gene, which encodes
polycystin-1, a G-protein coupled receptor (GPCR) [97].
Complete mutational inactivation of both alleles is rare
and lethal pre- or peri-natally [96]; however, incompletely
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penetrant PKD1 alleles have been found in homozygosis
[98]. Mutations in another gene, PKD2, are found in about
10% of ADPKD cases [97]. PKD2 encodes polycystin-2, a
transmembrane calcium channel of the TRPP family which
was found to physically interact with polycystin-1 [99, 100].
The remaining ∼5% of ADPKD patients carry unknown
mutations other than PKD1 or PKD2 [101]. Because of
their clear implication in PKD etiology, PKD1 and PKD2
genes and corresponding polycystin-1 and polycystin-2 gene
products are being studied in much detail. Polycystin-1 and
polycystin-2 complexes were found to mediate cell-matrix
and cell-cell interactions, planar cell polarity, signal trans-
duction, and cilia-mediatedmechanosensation [96].We have
recently reported that cystic tissue from ADPKD patients
carrying a PKD1 mutation exhibited significant reduction
of the Bicaudal C (BICC1) gene expression [102]. Similarly,
Pkd1−/− mice displayed reduced Bicc1 protein specifically
in the kidneys [102], placing BICC1 genetically downstream
of PKD1. Mutations in the BicC gene of many vertebrates,
including humans, cause the development of renal cysts [103–
110]. BicC was originally discovered in the fly during a screen
for embryonic polarity determinants in the germline [111].
Cyst formation is complex and unfolds over time.
ADPKD patients carrying PKD1 or PKD2 mutations already
display small renal cysts at birth [96] yet remain asymp-
tomatic until middle age because the renal capacity is in vast
excess (in fact, donation of one kidney is compatible with
life). After then, kidney function declines rapidly. Because
polycystin-1 and polycystin-2 are part of multiple protein
complexes with wide cellular distribution, dysregulation of
either in the renal tubule affects many pathways, including
apicobasal and planar cell polarity, cell proliferation, cell
metabolism, fluid secretion, and the extracellularmatrix [112–
115]. In PKD cysts form in the renal tubular epitheliumwhere
some cells reactivate normally quiescent proliferation path-
ways and begin to divide. In parallel, epithelial polarization
is progressively lost, impacting secretion. Fluid accumulation
in the cysts, in turn, stimulates further cell division, possibly
in response to increased tensional stretch in the tissue [116,
117]. It is currently unclear what triggers cyst formation. As
cysts expand, tubular cells display activation of various signal
transduction pathwaysmediated byCa2+ and cAMP, e.g., Raf-
MEK-ERK [118, 119], the mammalian Target of Rapamycin
(mTOR), PI3-kinase-Akt, JAK-STAT, NF-kB, Wnt, Hippo,
and G-proteins [115, 118–130]. In spite of the enumeration
of these pathways, the mechanisms of cyst initiation and
progressive cystic degeneration remain largely unknown,
likely because of the anatomical complexity of the vertebrate
kidney and slow disease onset, which hinder experimental
probing.The BicC fly provided the first account of renal cysts
in Drosophila [102]. Modeling PKD in the fly may enable
biochemical characterization of the cystic tubule and define
the genetics of cyst formation and progression due to low
genetic redundancy, and may advance our understanding
of the core cystic processes. BicC encodes a conserved
cytoplasmic RNA-binding protein with orthologs in many
species [104, 105, 109, 131–133]. BicC can bind to multiple
mRNA targets and appeared to reduce their expression
posttranscriptionally [134]. The resulting target upregulation
in the oocytes from heterozygote BicC female flies was found
to disrupt anterior-posterior embryonic polarity [7, 115–
135], while BicC homozygotes displayed oogenesis arrest at
stage 10 [136]. Similar to ADPKD patients, BicC mutant flies
featured fluid-filled cysts in the MTs already at hatching;
over time the cysts enlarged and became more numerous
[102]. Compared to wild type, BicC flies were short-lived,
possibly a consequence of their defective renal function
[102]. BicC MTs also displayed extra branches, indicating
underlying developmental and polarity defects. Oocytes
from BicC mutant flies exhibited abnormal actin structures
which prevented secretion of the dorsal fate determinant
Gurken [137–141]. Similarly, the BicC proteinwas required for
epithelial polarization via cadherin-mediated cell adhesion
in the IMCD murine kidney cell line [142]. Initial molecular
analyses of the BicC MTs identified the activation of the myc
and TOR pathways, two hallmarks of vertebrate PKD [102].
Like ADPKD patients, postrenal transplantation (in which
diseased kidneys are left in place) and administration of the
immune suppressant and TOR inhibitor rapamycin could
transiently rescue the BicC flies and reduce cysts, relative to
untreated controls [102, 126].Murine PKDmodels also exhib-
ited mTOR cascade stimulation [143–148] and responded
to rapamycin by delaying cystic onset [126, 145, 149]. In
sum, the BicC cystic flies appeared to recapitulate many
of the diseased features of PKD, displayed pharmacological
response to rapamycin [102], and may be a valid model to
advance our understanding of the molecular bases of renal
cyst formation and the formation of extra tubular branches.
One interesting aspect is that ciliary (dys)function appears
prominent in vertebrate PKD [150]. The absence of ciliated
epithelia in Drosophila raises the intriguing question of how
cysts form and develop in BicCMTs versus human nephrons.
Considering that other ciliary pathways, e.g., hedgehog, were
originally discovered in the fly, the striking biochemical
similarities between PKD-type cysts and the BicC-dependent
cysts in the fly may not be as surprising and may suggest new
hypotheses on the evolution of ciliary function.
With proper consideration of the differences between flies
and humans and of the hierarchical relationship between
the BicC and PKD1 genes, the BicC cystic fly may offer
opportunity to chart conserved pathways that are altered
in BicC mutation, are relevant for cyst formation and/or
progression, may allow to form new hypotheses on BicC
function and disease mechanism, and contribute to our
understanding of the larger functional context of human
PKD. Considering that BicC was also found in a protein
complex linked to human nephronophthisis, another cystic
kidney disease [110, 133], future studies will reveal if BicC
function may affect multiple pathways of renal cystogenesis.
5. Conclusion
The remarkable conservation of renal functions between fruit
flies and humans is suggestive of the presence of strong
evolutionary constraints imposed on the detoxification pro-
cess of all organisms. Emerging evidence of the interplay
between renal and immune functions suggests additional
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requirements for the renal system. Multiple diseases causing
progressive degeneration and loss of function of the kidney
result in organ damage that may only be remedied by renal
replacement therapy or dialysis, which are costly socially
for the health care system and personally to the patients
and their families, due to their negative impact on quality
of life. Studies aiming at understanding the mechanisms
of renal disease have been hindered by the anatomical
complexity of the mammalian kidney. Drosophila possesses
an evolutionary intermediate between glomerular and non-
glomerular renal system, consisting of anatomically separated
renal tubules and nephrocytes that, together, fulfill the renal
functions. Similar developmental origin of the fly MTs and
nephrocytes with their human counterparts, the nephron and
the glomerular podocytes, respectively, is accompanied by
conserved cellular pathways. Making the fruit fly a useful
model to study the mechanisms of disease, the structurally
streamlined, anatomically isolated, renal structures can be
easily microdissected and studied biochemically; moreover,
they can be probed genetically utilizing the vast array of
Drosophila genetic tools. In multiple cases in which human
renal disease has been modeled in Drosophila, including
nephrolithiasis and PKD, the conservation seemed to extend
to pharmacological responses, echoing similar examples in
other fly diseasemodels. Considering thatmany drug binding
sites were found to be conserved in the fly [151], development
of proper pharmacological screen protocols in the fly may in
future provide a rapid and effective alternative strategy for
drug discovery.
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